We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ABDX market cap is 12.78M. The company's latest EPS is GBP -0.0284 and P/E is -3.70.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 2.28M | 5.24M | 11.62M | 2.84M | 4.05M |
| Operating Income | -1.4M | -3.31M | -6.46M | -20.84M | -3.54M |
| Net Income | -1.26M | -3.37M | -6.97M | -21.26M | -3.45M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 7.33M | 10.97M | 33.23M | 12.77M | 6.06M |
| Total Liabilities | 1.24M | 8.22M | 11.9M | 6.34M | 3.05M |
| Total Equity | 6.09M | 2.75M | 21.33M | 6.43M | 3.01M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -908k | 2.1M | -12.88M | -7.74M | 914k |
| Investing | -79k | -1.94M | -7.28M | -756k | -68k |
| Financing | 1.38M | 3.37M | 20.74M | 5.92M | -7k |
| Market Cap | 12.78M |
| Price to Earnings Ratio | -3.70 |
| Price to Sales Ratio | 3.16 |
| Price to Cash Ratio | 3.95 |
| Price to Book Ratio | 4.25 |
| Dividend Yield | - |
| Shares Outstanding | 121.72M |
| Average Volume (1 week) | 122.44k |
| Average Volume (1 Month) | 227.91k |
| 52 Week Change | 27.27% |
| 52 Week High | 18.00 |
| 52 Week Low | 6.75 |
| Spread (Intraday) | 1 (9.09%) |
| Company Name | Abingdon Health Plc |
| Address |
york biotech campus york YO41 1LZ |
| Website | https://www.abingdonhealth.com |
| Industry | chemicals & chem preps, nec (2899) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
